BCM
CORZ icon

Bayesian Capital Management’s Core Scientific CORZ Stock Holding History

Bayesian Capital Management’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,300
Closed -$375K – 738
2024
Q2 		$375K Buy
+40,300
New +$206K 0.04% 446

Other funds holding CORZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $508M AUM 83.62% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $849M AUM 28.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bayesian Capital Management's CORZ Position: Q3 2024 in Review

Bayesian Capital Management sold out of Core Scientific (CORZ) in Q3 2024, closing a stake of 40,300 shares — an estimated $375K sold.

Bayesian Capital Management first reported a position in CORZ in Q2 2024 and held it in 1 quarter. The position peaked at $375K in Q2 2024. 249 funds tracked by Wall St. Rank hold CORZ as of Q3 2024.

  • Bayesian Capital Management reported no remaining Core Scientific position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 40,300 Core Scientific shares in Q3 2024, an estimated $375K.
  • Bayesian Capital Management first reported a position in Core Scientific in Q2 2024 and held it in 1 quarter.
  • Bayesian Capital Management's Core Scientific position peaked at $375K in Q2 2024.
  • 249 funds tracked by Wall St. Rank held Core Scientific as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.